1. Home
  2. COCP vs NXPL Comparison

COCP vs NXPL Comparison

Compare COCP & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • NXPL
  • Stock Information
  • Founded
  • COCP N/A
  • NXPL 1997
  • Country
  • COCP United States
  • NXPL United States
  • Employees
  • COCP N/A
  • NXPL N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • NXPL Telecommunications Equipment
  • Sector
  • COCP Health Care
  • NXPL Telecommunications
  • Exchange
  • COCP Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • COCP 20.1M
  • NXPL 19.5M
  • IPO Year
  • COCP N/A
  • NXPL N/A
  • Fundamental
  • Price
  • COCP $1.98
  • NXPL $1.11
  • Analyst Decision
  • COCP Strong Buy
  • NXPL
  • Analyst Count
  • COCP 1
  • NXPL 0
  • Target Price
  • COCP $7.00
  • NXPL N/A
  • AVG Volume (30 Days)
  • COCP 93.7K
  • NXPL 889.1K
  • Earning Date
  • COCP 11-13-2024
  • NXPL 11-14-2024
  • Dividend Yield
  • COCP N/A
  • NXPL N/A
  • EPS Growth
  • COCP N/A
  • NXPL N/A
  • EPS
  • COCP N/A
  • NXPL N/A
  • Revenue
  • COCP N/A
  • NXPL $66,482,000.00
  • Revenue This Year
  • COCP N/A
  • NXPL N/A
  • Revenue Next Year
  • COCP N/A
  • NXPL N/A
  • P/E Ratio
  • COCP N/A
  • NXPL N/A
  • Revenue Growth
  • COCP N/A
  • NXPL 179.89
  • 52 Week Low
  • COCP $1.33
  • NXPL $0.71
  • 52 Week High
  • COCP $3.26
  • NXPL $2.68
  • Technical
  • Relative Strength Index (RSI)
  • COCP 44.30
  • NXPL 48.71
  • Support Level
  • COCP $2.21
  • NXPL $1.09
  • Resistance Level
  • COCP $2.60
  • NXPL $2.30
  • Average True Range (ATR)
  • COCP 0.33
  • NXPL 0.21
  • MACD
  • COCP -0.07
  • NXPL -0.03
  • Stochastic Oscillator
  • COCP 4.81
  • NXPL 5.56

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: